-
EP4204446
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP Citations: EP4204446
| Cited in | International search | Type: | Patent literature | Publication No.: | WO2021156490
[XPI] (VIB VZW et al.) | Type: | Non-patent literature | Publication information: | [ID] DANIEL WRAPP ET AL: "Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies", CELL, vol. 181, no. 5, 28 May 2020 (2020-05-28), Amsterdam NL, pages 1004 - 1015.e15, XP055764639, ISSN: 0092-8674, DOI: 10.1016/j.cell.2020.04.031 | DOI: | http://dx.doi.org/10.1016/j.cell.2020.04.031 | Type: | Non-patent literature | Publication information: | [I] DATABASE GenBank [online] 4 May 2020 (2020-05-04), WRAPP D ET AL: "Lama glama immunoglobulin heavy chain variable region mRNA, partial cds", XP055864500, retrieved from https://www.ncbi.nlm.nih.gov/nuccore/MT350284.1/ Database accession no. MT350284 | Type: | Non-patent literature | Publication information: | [I] WU YANLING ET AL: "Identification of Human Single-Domain Antibodies against SARS-CoV-2", CELL HOST & MICROBE, ELSEVIER, NL, vol. 27, no. 6, 14 May 2020 (2020-05-14), pages 891, XP086178478, ISSN: 1931-3128, [retrieved on 20200514], DOI: 10.1016/J.CHOM.2020.04.023 | DOI: | http://dx.doi.org/10.1016/j.chom.2020.04.023 | Type: | Non-patent literature | Publication information: | [I] SCHOOF MICHAEL ET AL: "An ultra-potent synthetic nanobody neutralizes SARS-CoV-2 by locking Spike into an inactive conformation", BIORXIV, 17 August 2020 (2020-08-17), XP055865529, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1101/2020.08.08.238469 | Type: | Non-patent literature | Publication information: | [I] XIANG YUFEI ET AL: "Versatile, Multivalent Nanobody Cocktails Efficiently Neutralize SARS-CoV-2", BIORXIV, 25 August 2020 (2020-08-25), United States, XP055852802, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1101/2020.08.24.264333 | Type: | Non-patent literature | Publication information: | [ID] HUO JIANGDONG ET AL: "Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2", NAT. STRUCT. MOL. BIOL, NATURE PUBLISHING GROUP US, NEW YORK, vol. 27, no. 9, 13 July 2020 (2020-07-13), pages 846 - 854, XP037271196, ISSN: 1545-9993, [retrieved on 20200713], DOI: 10.1038/S41594-020-0469-6 | DOI: | http://dx.doi.org/10.1038/s41594-020-0469-6 | Type: | Non-patent literature | Publication information: | [I] THOMAS J. ESPARZA ET AL: "High Affinity Nanobodies Block SARS-CoV-2 Spike Receptor Binding Domain Interaction with Human Angiotensin Converting Enzyme", BIORXIV, 24 July 2020 (2020-07-24), XP055763653, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1101/2020.07.24.219857 | Type: | Non-patent literature | Publication information: | [AP] ZUPANCIC JENNIFER M. ET AL: "Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS-CoV-2 Variants", ADVANCED THERAPEUTICS, vol. 4, no. 8, 2 August 2021 (2021-08-02), pages 2100099, XP055865509, ISSN: 2366-3987, Retrieved from the Internet | DOI: | http://dx.doi.org/10.1002/adtp.202100099 | Cited in | by applicant | Type: | Non-patent literature | Publication information: | HUO ET AL.: "Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2", NAT STRUCT MOL BIOL., vol. 27, no. 9, 2020, pages 846 - 54, XP037271196, DOI: 10.1038/s41594-020-0469-6 | DOI: | http://dx.doi.org/10.1038/s41594-020-0469-6 | Type: | Non-patent literature | Publication information: | WRAPP ET AL.: "Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies", CELL, vol. 181, no. 5, 2020, pages 1004 - 15, XP055764639, DOI: 10.1016/j.cell.2020.04.031 | DOI: | http://dx.doi.org/10.1016/j.cell.2020.04.031 | Type: | Non-patent literature | Publication information: | SMITHWATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482 | Type: | Non-patent literature | Publication information: | NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443 | Type: | Non-patent literature | Publication information: | PEARSONLIPMAN, PROC. NAT'L. ACAD. SCI. USA, vol. 85, 1988, pages 2444 | Type: | Non-patent literature | Publication information: | AUSUBEL ET AL., CURRENT PROTOCOLS IN MOLECULAR BIOLOGY, 1992 | Type: | Non-patent literature | Publication information: | KABAT, E.A. ET AL.: "Sequences of Proteins of Immunological Interest", 1991, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, pages: 91 - 3242 | Type: | Non-patent literature | Publication information: | VERED KUNIK ET AL., NUCLEIC ACIDS RESEARCH, vol. 40, 1 July 2012 (2012-07-01), pages W521 - W524 | Type: | Non-patent literature | Publication information: | CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877 | Type: | Non-patent literature | Publication information: | CHOTHIA, C. ET AL., J. MOL. BIOL., vol. 196, 1987, pages 901 - 917 | Type: | Non-patent literature | Publication information: | AL-LAZIKANI ET AL., J. MOLEC. BIOL., vol. 273, 1997, pages 927 - 948 | Type: | Non-patent literature | Publication information: | ALMAGRO, J. MOL. RECOGNIT., vol. 17, 2004, pages 132 - 143 | Type: | Non-patent literature | Publication information: | YANG, D.SINGH, A.WU, H.KROE-BARRETT, R.: "Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics", ANALYTICAL BIOCHEMISTRY, vol. 508, 2016, pages 78 - 96, XP029642360, DOI: 10.1016/j.ab.2016.06.024 | DOI: | http://dx.doi.org/10.1016/j.ab.2016.06.024 | Type: | Non-patent literature | Publication information: | PINTO ET AL.: "Cross-neutralization of SARS-Coll 2 by a human monoclonal SARS-CoV antibody", NATURE, vol. 583, 2020, pages 290 - 95 | Type: | Non-patent literature | Publication information: | "Current Protocols in Molecular Biology", 1992, JOHN WILEY & SONS | Type: | Non-patent literature | Publication information: | SAMBROOK ET AL.: "Molecular Cloning: a Laboratory Manual", 1989, COLD SPRING HARBOR LABORATORY PRESS | Type: | Non-patent literature | Publication information: | "Remington's Pharmaceutical Sciences", 1980 | Type: | Non-patent literature | Publication information: | BAUD D ET AL.: "Real estimates of mortality following COVID-19 infection.", LANCET INFECTDIS., vol. 20, 2020, pages S1473 - 3099 | Type: | Non-patent literature | Publication information: | LINDSEY R. BADENERIC J. RUBIN: "Covid-19 - The Search for Effective Therapy", N ENGL JMED., 2020 | Type: | Non-patent literature | Publication information: | ZIEGLER ET AL.: "SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues", CELL, 2020 |